GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Anbio Biotechnology NNNN · USD

Health Care · US listing · 🇺🇸 United States

Compare

3.32

-9.04%

Close of 20 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Anbio Biotechnology — daily NNNN Delayed
Market value
$145.7m
Last close × shares
Volume
79.5k
Shares, 20 Nov 2026
Price to earnings
25.2

About Anbio Biotechnology

Its shares trade under the ticker NNNN. It has been listed since 19 February 2025. In the fiscal year to 31 December 2025, it reported revenue of $8.6m and net income of $6.4m. At that date it held total assets of $30.2m and shareholders' equity of $30.2m.

Anbio Biotechnology is a DE-based company operating in Biotechnology industry. The company is headquartered in Frankfurt, Hessen. The company went IPO on 2025-02-19. Anbio Biotechnology is a Germany-based company. The firm is primarily engaged in the manufacturing of In Vitro Diagnostic Substance.

Figures and description from our data supplier, not checked against the company's own report.

More about Anbio Biotechnology →

Latest on Anbio Biotechnology

Our reporting

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Anbio Biotechnology's ticker?

Anbio Biotechnology trades as NNNN on its US listing, under ISIN KYG0367B1059.

What was Anbio Biotechnology's last closing price?

3.32 on 20 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.